Product Images Sildenafil

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 10 images provide visual information about the product associated with Sildenafil NDC 68001-363 by Bluepoint Laboratories, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

image 01

image 01

This is a medication called Sildenafil Tablets, which come in a film-coated tablet form. Each tablet contains 20mg of sildenafil citrate, a medication for treating erectile dysfunction. The usual dosage is to be determined by the prescribing information for Dosage and Administration. It should be stored between 20° to 25°C (68° to 77°F) and out of reach of children. It is manufactured by Macleods Pharmaceuticals Limited and distributed by BluePoint Laboratories.*

SILDENAFIL Label 20mg 90ct_Rev 06-18 - sildenafil 90s

SILDENAFIL Label 20mg 90ct_Rev 06-18 - sildenafil 90s

The text describes a medication called Sildenafil Tablets, USP with a concentration of 20mg/tablet. The medication should be stored at 20-25°C (68-77°F) with permitted excursions to 15-30°C (59-86°F) and dispensed in tight containers. Please see prescribing information for dosage and administration. The medication is manufactured for BluePoint Laboratories by Macleods Pharmaceuticals Ltd in Himachal Pradesh, India. Pharmacist should dispense the medication with the attached patient information leaflet and keep out of reach of children.*

figure-10 - sildenafil fig 10

figure-10 - sildenafil fig 10

figure-11 - sildenafil fig 11

figure-11 - sildenafil fig 11

Figure 12 - sildenafil fig 12

Figure 12 - sildenafil fig 12

The text provides a graph displaying the change from baseline in meters for different treatments at various study weeks. The treatments include Sildenafil at 1mg, 5mg, and 20mg TID. The graph shows the mean change from baseline with the Standard Error at each visit up to week 12.*

fig-6 - sildenafil fig 6

fig-6 - sildenafil fig 6

fig-8 - sildenafil fig 8

fig-8 - sildenafil fig 8

The text is a chart that shows recommendations on dose adjustments for interacting drugs, along with their fold change and 90% CI. The drugs are listed in alphabetical order, and some require adjustment while others do not. There are also asterisks indicating specific notes or warnings about certain drug interactions.*

Figure 9 - sildenafil fig 9

Figure 9 - sildenafil fig 9

figure-7 - sildenafil figure 7

figure-7 - sildenafil figure 7

This text appears to be a table that shows the drug fold change and %0% CI recommendation for various drugs. It provides information on the adjustment of doses for drugs such as Atorastin, Astromycn, Bosentan, Cimetidine, Evermyel, and Saquinavie. It also mentions that there is no need for dose adjustment when taking Oral Contraceptives. There is a note that co-administration of drugs with sildenafil is not recommended. However, the text also mentions that there is no benefit in adding sildenafil to bosentan therapy when it comes to exercise capacity. The table also includes a graph with a solid line at x=1, indicating a change in relation to sildenafil alone. Overall, this text appears to be a medical document providing information on drug interaction and recommendations.*

str - sildenafil str

str - sildenafil str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.